Who
Kristian Reich
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, MoonLake Immunotherapeutics.
In numbers
- Trades disclosed
- 56
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $24.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Apr 2023
- Last trade
- 27 Jul 2026
- Last filed
- 29 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Jul 2026filed 29 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $22K1,100 at $20.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $22K1,100 at $20.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $49K2,448 at $20.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $49K2,448 at $20.00 | filing |
| 21 Jul 2026filed 23 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $1.0M50,000 at $20.02 | filing |
| 21 Jul 2026filed 23 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $1.0M50,000 at $20.02 | filing |
| 20 Jul 2026filed 21 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $878K43,700 at $20.09 | filing |
| 20 Jul 2026filed 21 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $878K43,700 at $20.09 | filing |
| 15 Jul 2026filed 20 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $322K16,105 at $20.01 | filing |
| 15 Jul 2026filed 20 Jul 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $322K16,105 at $20.01 | filing |
| 17 Jun 2026filed 17 Jun 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $972K50,000 at $19.43 | filing |
| 17 Jun 2026filed 17 Jun 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $972K50,000 at $19.43 | filing |
| 16 Jun 2026filed 17 Jun 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $935K50,000 at $18.70 | filing |
| 16 Jun 2026filed 17 Jun 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $935K50,000 at $18.70 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $945K50,000 at $18.89 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $945K50,000 at $18.89 | filing |
| 7 Jan 2026filed 9 Jan 2026 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —520,342 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —520,342 at $0.00 | filing |
| 19 Dec 2025filed 22 Dec 2025 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,052 | filing |
| 19 Dec 2025filed 22 Dec 2025 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Code C | —35,389 | filing |
News
No headline names them, or the companies they trade most, lately.